Fresenius Kabi AG - Strategic SWOT Analysis Review

August 2019 | 53 pages | ID: FE1806E499CEN
GlobalData

Abstracts

Fresenius Kabi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Fresenius Kabi AG (Fresenius Kabi), a wholly owned subsidiary of Fresenius SE & Co KGaA, develops, manufactures and markets pharmaceuticals products and medical devices. Its product portfolio includes intravenously administered drugs, infusion therapy products, medical devices and clinical nutrition products. The company's therapeutic expertise covers areas of blood volume substitution, fluid management, anesthesia, critical illness, liver insufficiency, renal insufficiency, maldigestion or malabsorption, diabetes mellitus and pediatrics. Its products and services are indicated for the treatment of critically and chronically ill patients.

Fresenius Kabi AG Key Recent Developments

Apr 08,2019: Fresenius Kabi celebrates $100 M Wilson Pharma expansion
Mar 01,2019: Akorn comments on favorable court order
Dec 10,2018: Fresenius Kabi announces U.S. availability of Omegaven (fish oil triglycerides) Injectable Emulsion
Dec 03,2018: Fresenius Kabi receives FDA drug shortage assistance award
Nov 29,2018: Fresenius Kabi is among the most reputable companies in Germany

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Fresenius Kabi AG - Key Facts
Fresenius Kabi AG - Key Employees
Fresenius Kabi AG - Key Employee Biographies
Fresenius Kabi AG - Key Operational Employees
Fresenius Kabi AG - Major Products and Services
Fresenius Kabi AG - History
Fresenius Kabi AG - Company Statement
Fresenius Kabi AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Fresenius Kabi AG - Business Description
Business Segment: Clinical Nutrition Products
Overview
Performance
Business Segment: Infusion Therapy Products
Overview
Performance
Business Segment: IV Drugs
Overview
Performance
Key Stats
Business Segment: Medical Devices and Transfusion Technology
Overview
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Latin America/Africa
Performance
Geographical Segment: North America
Performance
R&D Overview
Fresenius Kabi AG - Corporate Strategy
Fresenius Kabi AG - SWOT Analysis
SWOT Analysis - Overview
Fresenius Kabi AG - Strengths
Fresenius Kabi AG - Weaknesses
Fresenius Kabi AG - Opportunities
Fresenius Kabi AG - Threats
Fresenius Kabi AG - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Fresenius Kabi AG, Medical Equipment, Deals By Year, 2013 to YTD 2019
Fresenius Kabi AG, Medical Equipment, Deals By Type, 2013 to YTD 2019
Fresenius Kabi AG, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Apr 08, 2019: Fresenius Kabi celebrates $100 M Wilson Pharma expansion
Mar 01, 2019: Akorn comments on favorable court order
Dec 10, 2018: Fresenius Kabi announces U.S. availability of Omegaven (fish oil triglycerides) Injectable Emulsion
Dec 03, 2018: Fresenius Kabi receives FDA drug shortage assistance award
Nov 29, 2018: Fresenius Kabi is among the most reputable companies in Germany
Nov 27, 2018: Winner of Fresenius Kabi's Clinical Nutrition research grant Latin America to begin study on omega-3 fatty acids
Nov 20, 2018: Fresenius Kabi issues voluntary nationwide recall of sodium chloride injection, USP, 0.9% due to product labeling incorrectly stating stoppers do not contain latex
Oct 30, 2018: Fresenius in Q3/18 with continued strong Group earnings growth in constant currency
Oct 12, 2018: Fresenius Kabi opens compounding center in Canada
Oct 11, 2018: Fresenius Kabi Opens New Pharmaceutical Compounding Centre in Mississauga, Ontario

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Fresenius Kabi AG, Key Facts
Fresenius Kabi AG, Key Employees
Fresenius Kabi AG, Key Employee Biographies
Fresenius Kabi AG, Key Operational Employees
Fresenius Kabi AG, Major Products and Services
Fresenius Kabi AG, History
Fresenius Kabi AG, Other Locations
Fresenius Kabi AG, Subsidiaries
Fresenius Kabi AG, Joint Venture
Fresenius Kabi AG, Key Competitors
Fresenius Kabi AG, Medical Equipment, Deals By Year, 2013 to YTD 2019
Fresenius Kabi AG, Medical Equipment, Deals By Type, 2013 to YTD 2019
Fresenius Kabi AG, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Fresenius Kabi AG, Medical Equipment, Deals By Year, 2013 to YTD 2019
Fresenius Kabi AG, Medical Equipment, Deals by Type, 2013 to YTD 2019

COMPANIES MENTIONED

Abbott Laboratories
Baxter Healthcare Corp
Becton Dickinson and Co
Freya Global L.L.P
Hospira Inc
Sandoz Inc
Teva Pharmaceutical Industries Ltd